Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Reliq Health Technologies's revenue per share for the
three
months ended in Sep. 2022 was $0.01.
Reliq Health Technologies's revenue per share for the trailing twelve months (TTM) ended in Sep. 2022 was $0.04.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Reliq Health Technologies's Revenue per Share or its related term are showing as below:
RQHTF's 3-Year Revenue Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 6.9 * Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Reliq Health Technologies Revenue per Share Related Terms
Reliq Health Technologies Revenue per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RQHTF vs VEEV, GEHC, RCM: Revenue per Share Comparison
For the Health Information Services subindustry, Reliq Health Technologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Reliq Health Technologies PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Reliq Health Technologies's PS Ratio distribution charts can be found below:
* The bar in red indicates where Reliq Health Technologies's PS Ratio falls into.
Reliq Health Technologies Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Reliq Health Technologies's Revenue Per Share for the fiscal year that ended in Jun. 2022 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.04
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Reliq Health Technologies (RQHTF) has a Revenue per Share of $0.04 as of Sep. 2022. Revenue per share equals the per-share value of a company's sales. View historical data on Reliq Health Technologies and its competitors.
Is Reliq Health Technologies' Revenue per Share too high?
Reliq Health Technologies' current Revenue per Share is $0.04. The Healthcare Providers & Services industry median Revenue per Share is 6.90. Reliq Health Technologies' value of $0.04 is 99.4% below this industry median. Overall, Reliq Health Technologies has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Reliq Health Technologies' Revenue per Share compare to VEEV and GEHC?
Reliq Health Technologies' Revenue per Share of $0.04 can be compared against companies in the Healthcare Providers & Services industry. The industry median Revenue per Share is 6.90. Reliq Health Technologies' value of $0.04 is 99.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Healthcare Providers & Services company?
The median Revenue per Share among Healthcare Providers & Services companies is 6.90, based on 612 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Reliq Health Technologies's current Revenue per Share of $0.04 is 99.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Reliq Health Technologies and its competitors. For the Healthcare Providers & Services industry, the median Revenue per Share is 6.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Reliq Health Technologies's current Revenue per Share is $0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reliq Health Technologies stock overvalued right now?
Reliq Health Technologies (RQHTF) has a current Revenue per Share of $0.04. The current Revenue per Share is $0.04 and 99.4% below the Healthcare Providers & Services industry median of 6.90. Reliq Health Technologies' overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Reliq Health Technologies (RQHTF), the current Revenue per Share is $0.04 as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Reliq Health Technologies Inc specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring, telemedicine, and care collaboration. The company's IUGO health technology platform is a hardware and software solution that allows complex patients to receive high-quality care in the home, improving health outcomes, enhancing the quality of life for patients and families and reducing the cost of care delivery.
10GF Score
Get the complete analysis for RQHTF
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RQHTF has been successfully added to your 
